Whether you want to increase brand awareness, deliver a complex message or launch a new product, our digital magazine provides the perfect medium to communicate effectively with your audience in a fresh and engaging way. Our innovative magazine platform offers advertisers the opportunity to build a stronger brand and increase customer loyalty by delivering their message to a highly targeted readership in a unique, engaging and interactive format. Resources that are designed to provide understanding and clarity when it comes to issues that are, quite frankly, sometimes very. Published by a leading business intelligence company, Pharma Technology Focus draws on our strong in-house market data and industry expertise to analyse and anticipate trends in the pharma industry, offering our readers truly timely and valuable news and insights. Think Magazine evangelism pack 75.00 25.00 Think Magazine grab bag 20.00 Game Plan - Scratch & Dent 20.00 4.99 About Us: Focus Press was formed to publish materials based on the inspired Word of God. Originally launched in 2011, this title has been at the forefront of our dedication to pushing the boundaries of digital publishing. Pharma Technology Focus is one of 27 digital B2B magazines produced by our team of experienced writers, editors and designers. Our publications are designed in a bold, bright and beautiful style that pleases the eye while giving our business-minded readers all the facts, data and analysis they expect from an industry magazine. We have developed the traditional B2B publishing style into an engaging, interactive reading experience. Innovative B2B publishingĪt Pharma Technology Focus we supply our readers with all the latest business news and insights in a visually stunning and easy to use format.
Fokus magazine free#
Published monthly and free to read on all devices, this digital magazine brings together the latest insights and innovations from across the industry, including new discoveries, R&D and clinical trials, manufacturing technologies and supply chain management, as well as insiders’ views and in-depth analysis of the latest market and investment trends and regulatory changes affecting the industry. For instance, the National Network against Homophobia and Transphobia of Macedonia is organizing a fundraising event in Skopje Old Town on October 14, 2014, to aid Fokus in covering the defamation fine and cover court costs.Pharma Technology Focus is the essential reading material for decision-makers in the pharmaceutical industry, bringing you the latest news and analysis in an exciting, interactive format. Other civic organizations also sounded alarms after hearing of the fine decided by a Skopje court. This, nevertheless, means endangering the survival of the magazine and the livelihood of its staff. Mijalkov announced that, when Fokus staff paid the fine, he would donate the part of the money he receives to an orphanage. Purpose of payment: Donation for the reporters from Focus Therefore we urge within your capabilities to donate to the following bank account: Moreover, we believe that the support of the press and public will be a direct contribution to safeguarding the freedom of expression in Macedonia. We believe that our support will be a contribution for the survival of free thought and criticism towards the ways the government is practicing power in the country. Our colleagues are not able to pay the fee, therefore AJM appeals for mobilization and solidarity of the membership, the journalistic community and the public in Macedonia. A Fokus journalist and its editor-in-chief have to pay over 9,300 euros to the Director of the Macedonian Security and Counter-Intelligence Directorate Sasho Mijalkov, who brought the defamation law suit against them.ĪJM believes that the verdict is unfair and directed against critical journalism, which is essential for the functioning of Macedonian democracy.
The Association of Journalists of Macedonia (AJM) appealed in October 2014 to all journalists and citizens to show solidarity with the journalists of Fokus magazine, who are subject to what has been deemed by many as harsh punishment due to a lost defamation law suit for some of the investigative pieces they published.
0 kommentar(er)
